hepatitis C virus – Page 9 – HCV Guidance

Barriers to the treatment of hepatitis C. Patient, provider, and system factors

May 3, 2017
Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1

May 3, 2017
Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies

May 3, 2017
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

May 3, 2017
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis

May 3, 2017
Regression of splenic lymphoma after treatment of hepatitis C virus infection

May 3, 2017
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

May 3, 2017
Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria

May 3, 2017
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care

May 3, 2017
Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals

May 3, 2017